Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANO1 | Q5XXA6 | 19/20 | 0.54 |
| ▸ | ANO2 | Q9NQ90 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14803393 | 0.87 | ANO1 (0.58) | ANO1ANO2MEN1KMT2A | |
| SCHEMBL1951952 | 0.78 | ANO1 (0.61) | ANO1ANO2MEN1KMT2A | |
| SCHEMBL1951950 | 0.78 | ANO1 (0.61) | ANO1ANO2MEN1KMT2A | |
| SCHEMBL1897695 | 0.77 | ANO1 (0.58) | ANO1ANO2MEN1KMT2A | |
| SCHEMBL1897696 | 0.77 | ANO1 (0.58) | ANO1ANO2MEN1KMT2A | |
| SCHEMBL1952059 | 0.74 | ANO1 (0.55) | ANO1ANO2MEN1KMT2A | |
| SCHEMBL1952057 | 0.74 | ANO1 (0.55) | ANO1ANO2MEN1KMT2A | |
| SCHEMBL12271278 | 0.74 | ANO1 (0.80) | ANO1ANO2MEN1KMT2A | |
| SCHEMBL7943080 | 0.74 | ANO1 (0.50) | ANO1ANO2 | |
| SCHEMBL7952321 | 0.74 | KMT2A (0.65) | ANO1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8383670-B2 | Trisubstituted thiophenes that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2013-02-26 | — | — | US | disclosed |
| US-8383670-B2 | Trisubstituted thiophenes that modulate intracellular calcium | CALCIMEDICA, INC. (US) | 2013-02-26 | — | — | US | disclosed |
| US-20110212970-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2011-09-01 | — | — | US | disclosed |
| US-20110212970-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | CALCIMEDICA, INC. (US) | 2011-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110212970-A1 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | ORAI1, SARAF, RYR2 | ANO1 114/4885ANO2 98/4885MEN1 2958/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.